Cigna Group (CI) stock saw a modest uptick, ending the day at $283.99 which represents a slight increase of $3.02 or 1.07% from the prior close of $280.97. The stock opened at $281.09 and touched a low of $279.
We recently compiled a list of the Billionaire Lee Cooperman’s Top 15 Long-Term Stock Picks. In this article, we are going to take a look at where The Cigna Group (NYSE:CI) stands against Lee Cooperman’s other long-term stock picks.
Aaron Wealth Advisors LLC lifted its stake in The Cigna Group (NYSE:CI – Free Report) by 16.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 1,397 shares of the health services provider’s stock after purchasing an additional 198 shares during the period.
In a report released yesterday, Lance Wilkes from Bernstein maintained a Buy rating on Cigna (CI – Research Report), with a price target of
Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January 30, 2025, and will host a conference call the same day.
Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S.
A new offering in collaboration with Progyny, Inc makes fertility/family-building services more accessible and equitable.
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a look at where The Cigna Group (NYSE:CI) stands against other cheapest stocks with biggest upside potential.